Soy and isoflavone consumption and risk of gastrointestinal cancer: a systematic review and meta-analysis
- 782 Downloads
Evidence suggests that soy foods have chemoprotective properties that may reduce the risk of certain cancers such as breast and prostate cancer. However, data involving gastrointestinal (GI) have been limited, and the evidence remains controversial. This study aims to determine the potential relationship between dietary soy intake and GI cancer risk with an evaluation of the effects of isoflavone as an active soy constituent.
Relevant studies were identified after literature search via electronic databases through May 2014. Subgroup analysis for isoflavone intake (studies n = 10) was performed. Covariants including gender types, anatomical subsites and preparation methods were also evaluated. Pooled adjusted odds ratios (ORs) comparing highest and lowest categories of dietary pattern scores were calculated using a random effects model.
Twenty-two case–control and 18 cohort studies were included for meta-analysis, which contained a total of 633,476 participants and 13,639 GI cancer cases. The combined OR was calculated as 0.93 (95 % CI 0.87–0.99; p value heterogeneity = 0.01), showing only a slight decrease in risk, the association was stronger for colon cancer (OR 0.92; 95 % CI 0.96–0.99; p value heterogeneity = 0.163) and colorectal cancer (CRC) (OR 0.92; 95 % CI 0.87–0.97; p value heterogeneity = 0.3). Subgroup analysis for isoflavone intake showed a statistically significant risk reduction with a risk estimate of 0.73 (95 % CI 0.59–0.92; p value heterogeneity = 0), and particularly for CRC (OR 0.76; 95 % CI 0.59–0.98; p value heterogeneity = 0).
This study provides evidence that soy intake as a food group is only associated with a small reduction in GI cancer risk. Separate analysis for dietary isoflavone intakes suggests a stronger inverse association.
KeywordsSoy Isoflavone Gastrointestinal neoplasms Colon cancer Meta-analysis
- 3.Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L (1995) Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125:790S–797SGoogle Scholar
- 4.Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Le Pecq JB, Larsen AK (1989) Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49:5111–5117Google Scholar
- 5.Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shiyba M, Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific kinase. J Biol Chem 25:5592–5595Google Scholar
- 8.Wu AH, Yang D, Pike MC (2000) A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev 9:1051–1058Google Scholar
- 10.Clinton S, Destree R, Anderson D (1979) 1,2-Dimethylhydrazube induced intestinal cancer in rats fed beef or soy protein. Nutr Rep Int 20:335–342Google Scholar
- 11.Reddy B, Narisawa T, Weisburger J (1976) Effect of a diet with high levels of protein and fat on colon carcinogenesis in F344 rats treated with 1,2-Dimethylhydrazine. J Nat Cancer Inst 57:1559–1566Google Scholar
- 12.Monsma D, Eghtedary K, Klurfeld D (1997) Colon cancer and aberrant crpy formation in ras fed different types of meat. FASEB J 11:A576Google Scholar
- 13.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefGoogle Scholar
- 18.Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 288:321–333CrossRefGoogle Scholar
- 22.Govers MJ, Lapre JA, De Vries HT, Van der Meer R (1993) Dietary soybean protein compared with casein damages colonic epithelium and stimulates colonic epithelial proliferation in rats. J Nutr 123:1709–1713Google Scholar
- 25.You WC, Blot WJ, Chang YS, Ershow AG, Yang ZT, An Q, Henderson B, Xu GW, Fraumeni JF Jr, Wang TG (1988) Diet and high risk of stomach cancer in Shandong, China. Cancer Res 48:3518–3523Google Scholar
- 26.Kato I, Tominaga S, Ito Y, Kobayashi S, Yoshii Y, Matsuura A, Kameya A, Kano T (1990) A comparative case–control analysis of stomach cancer and atrophic gastritis. Cancer Res 50:6559–6564Google Scholar
- 33.Nishi M, Yoshida K, Hirata K, Miyake H (1997) Eating habits and colorectal cancer. Oncol Rep 4:995–998Google Scholar
- 36.Huang XE, Hirose K, Wakai K, Matsuo K, Ito H, Xiang J, Takezaki T, Tajima K (2004) Comparison of lifestyle risk factors by family history for gastric, breast, lung and colorectal cancer. APJCP 5:419–427Google Scholar
- 37.Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo M (2005) Nutritional risks and colorectal cancer in a Portuguese population. Nutr Hosp 20:165–172Google Scholar
- 38.Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P (2006) Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136:3046–3053Google Scholar
- 43.Ko KP, Park SK, Park B, Yang JJ, Cho LY, Kang C, Kim CS, Gwack J, Shin A, Kim Y, Kim J, Yang HK, Kang D, Chang SH, Shin HR, Yoo KY (2010) Isoflavones from phytoestrogens and gastric cancer risk: a nested case–control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev 19:1292–1300CrossRefGoogle Scholar
- 44.Budhathoki S, Joshi AM, Ohnaka K, Yin G, Toyomura K, Kono S, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R (2011) Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka colorectal cancer study. Scand J Gastroenterol 46:165–172CrossRefGoogle Scholar
- 45.Nomura A, Grove JS, Stemmermann GN, Severson RK (1990) A prospective study of stomach cancer and its relation to diet, cigarettes, and alcohol consumption. Cancer Res 50:627–631Google Scholar
- 52.Khan MM, Goto R, Kobayashi K, Suzumura S, Nagata Y, Sonoda T, Sakauchi F, Washio M, Mori M (2004) Dietary habits and cancer mortality among middle aged and older Japanese living in hokkaido, Japan by cancer site and sex. APJCP 5:58–65Google Scholar
- 53.Iso H, Kubota Y, Japan Collaborative Cohort Study for Evaluation of C (2007) Nutrition and disease in the Japan collaborative cohort study for evaluation of cancer (JACC). APJCP 8(Suppl):35–80Google Scholar
- 57.Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S, Japan Public Health Center-Based Prospective Study G (2008) Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study. Cancer Epidemiol Biomarkers Prev 17:2128–2135CrossRefGoogle Scholar
- 63.Willet WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228SGoogle Scholar